Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein

Authors: Gauri Shishodia, Gaurav Verma, Yogesh Srivastava, Ravi Mehrotra, Bhudev Chandra Das, Alok Chandra Bharti

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Aberrantly expressed and constitutively active STAT3 signaling plays a pivotal role in initiation and progression of human papillomavirus-induced cervical carcinogenesis. However, the underlying mechanism(s) responsible for pleiotropic effects of STAT3 signaling is poorly understood. In view of emerging regulatory role of microRNAs, Let-7a and miR-21 that may interact with STAT3 signaling and/or its downstream effectors, present study was designed in HPV16-positive cervical cancer cells to assess the functional contribution of these miRs in STAT3 signaling in cervical cancer.

Methods

Functional silencing of STAT3 signaling and HPV16 oncoprotein expression in SiHa cells was done by STAT3-specific and 16 E6 siRNAs. Pharmacological intervention of STAT3 was done using specific inhibitors like curcumin and stattic. Loss-of-function study of miR-21 using miR-21 inhibitor and gain-of-function study of let-7a was done using let-7a mimic in SiHa cells.

Results

Functional silencing of STAT3 signaling in SiHa cells by STAT3-specific siRNA resulted in a dose-dependent decrease in cellular miR-21 level. Pharmacological intervention of STAT3 using specific inhibitors like curcumin and Stattic that abrogated STAT3 activation resulted in loss of cellular miR-21 pool. Contrary to this, specific targeting of miR-21 using miR-21 inhibitor resulted in an increased level of PTEN, a negative regulator of STAT3, and reduced active pSTAT3 level. Besides miR-21, restoration of cellular Let-7a using chemically synthesized Let-7a mimic reduced overall STAT3 level. Abrogation of HPV oncoprotein E6 by specific siRNA resulted in increased Let-7a but loss of miR-21 and a correspondingly reduced pSTAT3/STAT3 and elevated the level of cellular PTEN.

Conclusions

Our results demonstrate existence of a functional loop involving Let-7a, STAT3 and miR-21 which were found potentially regulated by viral oncoprotein E6. Implications: miR-21 and Let-7a along with STAT3 may prove useful targets for pharmacological intervention for management of cervical cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chen CL, Hsieh FC, Lieblein JC, Brown J, Chan C, Wallace JA, Cheng G, Hall BM, Lin J: Stat3 activation in human endometrial and cervical cancers. Br J Cancer. 2007, 96 (4): 591-599. 10.1038/sj.bjc.6603597.CrossRefPubMedPubMedCentral Chen CL, Hsieh FC, Lieblein JC, Brown J, Chan C, Wallace JA, Cheng G, Hall BM, Lin J: Stat3 activation in human endometrial and cervical cancers. Br J Cancer. 2007, 96 (4): 591-599. 10.1038/sj.bjc.6603597.CrossRefPubMedPubMedCentral
2.
go back to reference Shukla S, Shishodia G, Mahata S, Hedau S, Pandey A, Bhambhani S, Batra S, Basir SF, Das BC, Bharti AC: Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Mol Cancer. 2010, 9: 282-10.1186/1476-4598-9-282.CrossRefPubMedPubMedCentral Shukla S, Shishodia G, Mahata S, Hedau S, Pandey A, Bhambhani S, Batra S, Basir SF, Das BC, Bharti AC: Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Mol Cancer. 2010, 9: 282-10.1186/1476-4598-9-282.CrossRefPubMedPubMedCentral
3.
go back to reference Shukla S, Mahata S, Shishodia G, Pandey A, Tyagi A, Vishnoi K, Basir SF, Das BC, Bharti AC: Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. PLoS One. 2013, 8 (7): e67849-10.1371/journal.pone.0067849.CrossRefPubMedPubMedCentral Shukla S, Mahata S, Shishodia G, Pandey A, Tyagi A, Vishnoi K, Basir SF, Das BC, Bharti AC: Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. PLoS One. 2013, 8 (7): e67849-10.1371/journal.pone.0067849.CrossRefPubMedPubMedCentral
4.
go back to reference Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B: Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci. 2009, 1171: 59-76. 10.1111/j.1749-6632.2009.04911.x.CrossRefPubMedPubMedCentral Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B: Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci. 2009, 1171: 59-76. 10.1111/j.1749-6632.2009.04911.x.CrossRefPubMedPubMedCentral
5.
go back to reference Kohanbash G, Okada H: MicroRNAs and STAT interplay. Semin Cancer Biol. 2012, 22 (1): 70-75. 10.1016/j.semcancer.2011.12.010.CrossRefPubMed Kohanbash G, Okada H: MicroRNAs and STAT interplay. Semin Cancer Biol. 2012, 22 (1): 70-75. 10.1016/j.semcancer.2011.12.010.CrossRefPubMed
6.
go back to reference Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY: miR-21-mediated tumor growth. Oncogene. 2007, 26 (19): 2799-2803. 10.1038/sj.onc.1210083.CrossRefPubMed Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY: miR-21-mediated tumor growth. Oncogene. 2007, 26 (19): 2799-2803. 10.1038/sj.onc.1210083.CrossRefPubMed
7.
go back to reference Esquela-Kerscher A, Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006, 6 (4): 259-269. 10.1038/nrc1840.CrossRefPubMed Esquela-Kerscher A, Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006, 6 (4): 259-269. 10.1038/nrc1840.CrossRefPubMed
8.
go back to reference Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002, 99 (24): 15524-15529. 10.1073/pnas.242606799.CrossRefPubMedPubMedCentral Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002, 99 (24): 15524-15529. 10.1073/pnas.242606799.CrossRefPubMedPubMedCentral
9.
go back to reference Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004, 101 (9): 2999-3004. 10.1073/pnas.0307323101.CrossRefPubMedPubMedCentral Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004, 101 (9): 2999-3004. 10.1073/pnas.0307323101.CrossRefPubMedPubMedCentral
10.
go back to reference Michael MZ SMOC, van Holst Pellekaan NG, Young GP, James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003, 1 (12): 882-891.PubMed Michael MZ SMOC, van Holst Pellekaan NG, Young GP, James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003, 1 (12): 882-891.PubMed
11.
go back to reference Lui WO, Pourmand N, Patterson BK, Fire A: Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007, 67 (13): 6031-6043. 10.1158/0008-5472.CAN-06-0561.CrossRefPubMed Lui WO, Pourmand N, Patterson BK, Fire A: Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007, 67 (13): 6031-6043. 10.1158/0008-5472.CAN-06-0561.CrossRefPubMed
12.
go back to reference Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One. 2008, 3 (7): e2557-10.1371/journal.pone.0002557.CrossRefPubMedPubMedCentral Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One. 2008, 3 (7): e2557-10.1371/journal.pone.0002557.CrossRefPubMedPubMedCentral
13.
go back to reference Chan JA, Krichevsky AM, Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65 (14): 6029-6033. 10.1158/0008-5472.CAN-05-0137.CrossRefPubMed Chan JA, Krichevsky AM, Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65 (14): 6029-6033. 10.1158/0008-5472.CAN-05-0137.CrossRefPubMed
14.
go back to reference Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, Cvijic H, Ullmann AK, Stadler PF, Horn F: Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood. 2007, 110 (4): 1330-1333. 10.1182/blood-2007-03-081133.CrossRefPubMed Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, Cvijic H, Ullmann AK, Stadler PF, Horn F: Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood. 2007, 110 (4): 1330-1333. 10.1182/blood-2007-03-081133.CrossRefPubMed
15.
go back to reference Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007, 133 (2): 647-658. 10.1053/j.gastro.2007.05.022.CrossRefPubMedPubMedCentral Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007, 133 (2): 647-658. 10.1053/j.gastro.2007.05.022.CrossRefPubMedPubMedCentral
16.
go back to reference Sun S, Steinberg BM: PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol. 2002, 83 (Pt 7): 1651-1658.CrossRefPubMed Sun S, Steinberg BM: PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol. 2002, 83 (Pt 7): 1651-1658.CrossRefPubMed
17.
go back to reference Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG: Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol. 2010, 53 (1): 57-66. 10.1016/j.jhep.2009.12.043.CrossRefPubMed Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow P, Chung AY, Jooi LL, Lee CG: Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol. 2010, 53 (1): 57-66. 10.1016/j.jhep.2009.12.043.CrossRefPubMed
18.
go back to reference Akao Y, Nakagawa Y, Naoe T: Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull. 2006, 29 (5): 903-906. 10.1248/bpb.29.903.CrossRefPubMed Akao Y, Nakagawa Y, Naoe T: Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull. 2006, 29 (5): 903-906. 10.1248/bpb.29.903.CrossRefPubMed
19.
go back to reference Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T: Reduced expression of the Let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64 (11): 3753-3756. 10.1158/0008-5472.CAN-04-0637.CrossRefPubMed Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T: Reduced expression of the Let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64 (11): 3753-3756. 10.1158/0008-5472.CAN-04-0637.CrossRefPubMed
20.
go back to reference Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB, Slack FJ: Regression of murine lung tumors by the Let-7 microRNA. Oncogene. 2010, 29 (11): 1580-1587. 10.1038/onc.2009.445.CrossRefPubMed Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB, Slack FJ: Regression of murine lung tumors by the Let-7 microRNA. Oncogene. 2010, 29 (11): 1580-1587. 10.1038/onc.2009.445.CrossRefPubMed
21.
go back to reference zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000, 92 (9): 690-698. 10.1093/jnci/92.9.690.CrossRefPubMed zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000, 92 (9): 690-698. 10.1093/jnci/92.9.690.CrossRefPubMed
22.
go back to reference Ren C, Cheng X, Lu B, Yang G: Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment. Eur J Cancer. 2013, 49 (18): 3889-3899. 10.1016/j.ejca.2013.07.140.CrossRefPubMed Ren C, Cheng X, Lu B, Yang G: Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment. Eur J Cancer. 2013, 49 (18): 3889-3899. 10.1016/j.ejca.2013.07.140.CrossRefPubMed
23.
go back to reference Androphy EJ, Hubbert NL, Schiller JT, Lowy DR: Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J. 1987, 6 (4): 989-992.PubMedPubMedCentral Androphy EJ, Hubbert NL, Schiller JT, Lowy DR: Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J. 1987, 6 (4): 989-992.PubMedPubMedCentral
24.
go back to reference Bharti AC, Donato N, Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol. 2003, 171 (7): 3863-3871. 10.4049/jimmunol.171.7.3863.CrossRefPubMed Bharti AC, Donato N, Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol. 2003, 171 (7): 3863-3871. 10.4049/jimmunol.171.7.3863.CrossRefPubMed
25.
go back to reference Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H: Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2006, 1091: 151-169. 10.1196/annals.1378.063.CrossRefPubMed Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H: Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2006, 1091: 151-169. 10.1196/annals.1378.063.CrossRefPubMed
26.
go back to reference Schust J, Sperl B, Hollis A, Mayer TU, Berg T: Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol. 2006, 13 (11): 1235-1242. 10.1016/j.chembiol.2006.09.018.CrossRefPubMed Schust J, Sperl B, Hollis A, Mayer TU, Berg T: Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol. 2006, 13 (11): 1235-1242. 10.1016/j.chembiol.2006.09.018.CrossRefPubMed
27.
go back to reference Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE, Kiviat NB: Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One. 2011, 6 (12): e28423-10.1371/journal.pone.0028423.CrossRefPubMedPubMedCentral Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE, Kiviat NB: Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One. 2011, 6 (12): e28423-10.1371/journal.pone.0028423.CrossRefPubMedPubMedCentral
29.
go back to reference Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell. 2010, 39 (4): 493-506. 10.1016/j.molcel.2010.07.023.CrossRefPubMedPubMedCentral Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell. 2010, 39 (4): 493-506. 10.1016/j.molcel.2010.07.023.CrossRefPubMedPubMedCentral
30.
go back to reference Li Y, Wu R, Liu Z, Fan J, Yang H: Enforced expression of microRNA-21 influences the replication of varicella-zoster virus by triggering signal transducer and activator of transcription 3. Exp Ther Med. 2014, 7 (5): 1291-1296.PubMedPubMedCentral Li Y, Wu R, Liu Z, Fan J, Yang H: Enforced expression of microRNA-21 influences the replication of varicella-zoster virus by triggering signal transducer and activator of transcription 3. Exp Ther Med. 2014, 7 (5): 1291-1296.PubMedPubMedCentral
31.
go back to reference Qin X, Yan L, Zhao X, Li C, Fu Y: microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett. 2012, 4 (6): 1290-1296.PubMedPubMedCentral Qin X, Yan L, Zhao X, Li C, Fu Y: microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett. 2012, 4 (6): 1290-1296.PubMedPubMedCentral
32.
go back to reference Iliopoulos D, Hirsch HA, Struhl K: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009, 139 (4): 693-706. 10.1016/j.cell.2009.10.014.CrossRefPubMedPubMedCentral Iliopoulos D, Hirsch HA, Struhl K: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009, 139 (4): 693-706. 10.1016/j.cell.2009.10.014.CrossRefPubMedPubMedCentral
33.
go back to reference Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y, Patel T: The MicroRNA Let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem. 2007, 282 (11): 8256-8264. 10.1074/jbc.M607712200.CrossRefPubMed Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y, Patel T: The MicroRNA Let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem. 2007, 282 (11): 8256-8264. 10.1074/jbc.M607712200.CrossRefPubMed
34.
go back to reference Wang Y, Hu X, Greshock J, Shen L, Yang X, Shao Z, Liang S, Tanyi JL, Sood AK, Zhang L: Genomic DNA copy-number alterations of the Let-7 family in human cancers. PLoS One. 2012, 7 (9): e44399-10.1371/journal.pone.0044399.CrossRefPubMedPubMedCentral Wang Y, Hu X, Greshock J, Shen L, Yang X, Shao Z, Liang S, Tanyi JL, Sood AK, Zhang L: Genomic DNA copy-number alterations of the Let-7 family in human cancers. PLoS One. 2012, 7 (9): e44399-10.1371/journal.pone.0044399.CrossRefPubMedPubMedCentral
35.
go back to reference Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T: Suppression of non-small cell lung tumor development by the Let-7 microRNA family. Proc Natl Acad Sci U S A. 2008, 105 (10): 3903-3908. 10.1073/pnas.0712321105.CrossRefPubMedPubMedCentral Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T: Suppression of non-small cell lung tumor development by the Let-7 microRNA family. Proc Natl Acad Sci U S A. 2008, 105 (10): 3903-3908. 10.1073/pnas.0712321105.CrossRefPubMedPubMedCentral
36.
go back to reference Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM: Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA. 2009, 15 (4): 637-647. 10.1261/rna.1442309.CrossRefPubMedPubMedCentral Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM: Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA. 2009, 15 (4): 637-647. 10.1261/rna.1442309.CrossRefPubMedPubMedCentral
37.
go back to reference Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene. 2008, 27 (18): 2575-2582. 10.1038/sj.onc.1210919.CrossRefPubMed Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene. 2008, 27 (18): 2575-2582. 10.1038/sj.onc.1210919.CrossRefPubMed
38.
go back to reference Au Yeung CL, Tsang TY, Yau PL, Kwok TT: Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene. 2011, 30 (21): 2401-2410. 10.1038/onc.2010.613.CrossRefPubMed Au Yeung CL, Tsang TY, Yau PL, Kwok TT: Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene. 2011, 30 (21): 2401-2410. 10.1038/onc.2010.613.CrossRefPubMed
39.
go back to reference Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F: siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene. 2003, 22 (38): 5938-5945. 10.1038/sj.onc.1206894.CrossRefPubMed Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F: siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene. 2003, 22 (38): 5938-5945. 10.1038/sj.onc.1206894.CrossRefPubMed
40.
go back to reference Jiang M, Milner J: Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 2002, 21 (39): 6041-6048. 10.1038/sj.onc.1205878.CrossRefPubMed Jiang M, Milner J: Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 2002, 21 (39): 6041-6048. 10.1038/sj.onc.1205878.CrossRefPubMed
41.
go back to reference Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M: Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007, 315 (5818): 1579-1582. 10.1126/science.1136319.CrossRefPubMed Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M: Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007, 315 (5818): 1579-1582. 10.1126/science.1136319.CrossRefPubMed
42.
go back to reference Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M: Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res. 2008, 36 (20): 6608-6619. 10.1093/nar/gkn666.CrossRefPubMedPubMedCentral Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M: Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res. 2008, 36 (20): 6608-6619. 10.1093/nar/gkn666.CrossRefPubMedPubMedCentral
43.
go back to reference Shen Y, Li Y, Ye F, Wang F, Wan X, Lu W, Xie X: Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Exp Mol Med. 2011, 43 (6): 358-366. 10.3858/emm.2011.43.6.039.CrossRefPubMedPubMedCentral Shen Y, Li Y, Ye F, Wang F, Wan X, Lu W, Xie X: Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Exp Mol Med. 2011, 43 (6): 358-366. 10.3858/emm.2011.43.6.039.CrossRefPubMedPubMedCentral
Metadata
Title
Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein
Authors
Gauri Shishodia
Gaurav Verma
Yogesh Srivastava
Ravi Mehrotra
Bhudev Chandra Das
Alok Chandra Bharti
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-996

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine